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Abstract
Introduction:  Mucopolysaccharidosis  is  a  hereditary  lysosomal  storage  disease,  which  develops
due to  a  deﬁciency  in  the  enzymes  that  play  a  role  in  the  metabolism  of  glycosaminoglycans
(GAG). The  incidence  of  mucopolysaccharidosis  is  1/25,000,  with  autosomal  recessive  inheri-
tance (except  for  MPS  II).  Mucopolysaccharidosis  occurs  in  seven  different  types,  each  with  a
different congenital  deﬁciency  of  lysosomal  enzymes.  In  mucopolysaccharidosis  patients,  even
though progression  of  clinical  ﬁndings  is  not  prominent,  the  disease  advances  and  causes  death
at early  ages.  Facial  dysmorphism,  growth  retardation,  mental  retardation,  and  skeletal  or  joint
dysplasia are  the  most  frequently  found  symptoms  in  these  patients.
Objective:  The  purpose  of  our  study  is  to  present  the  types  of  hearing  loss  types  and  tympano-
metric ﬁndings  of  patients  with  mucopolysaccharidosis  referred  to  our  clinic  with  suspicion  of
hearing loss.
Methods:  After  otorhinolaryngological  examination,  9  patients  with  different  types  of
mucopolysaccharidosis,  underwent  to  immittance  and  audiometric  evaluations,  performed
according  to  their  physical  and  mental  abilities,  and  ages,  in  order  to  determine  their  hearing
thresholds.
Results: The  audiometric  ﬁndings  of  the  9  patients  followed  with  mucopolysaccharidosis  were
reported separately  for  each  case. Please cite this article as: Gökdog˘an C¸, Altinyay S¸, Gökdog˘an O, Tutar H, Gündüz B, Okur I˙, et al. Audiologic evaluations of children with
mucopolysaccharidosis. Braz J Otorhinolaryngol. 2016;82:281--4.
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Conclusion:  Based  on  the  high  frequency  of  hearing  loss  in  mucopolysaccharidosis  patients,
early and  detailed  audiological  evaluations  are  highly  desirable.  Therefore,  regular  and  sys-
tematic  multidisciplinary  evaluations  are  very  important.
© 2015  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Published  by
Elsevier Editora  Ltda.  All  rights  reserved.
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Resumo
Introduc¸ão:  Mucopolissacaridose  (MPS)  é  uma  doenc¸a  hereditária  de  depósito  lisossômico,
decorrente  da  deﬁciência  das  enzimas  que  inﬂuenciam  o  metabolismo  dos  glicosaminoglicanos
(GAGs). A  incidência  de  MPS  é  de  1/25.000  habitantes,  resultante  de  heranc¸a  autossômica
recessiva (exceto  no  caso  de  MPS  II).  MPS  se  apresenta  na  forma  de  sete  tipos  diferentes  e,
em cada  tipo,  ocorre  uma  deﬁciência  congênita  distinta  de  enzimas  lisossômicas.  Embora  em
pacientes  com  MPS  os  achados  clínicos  não  sejam  geralmente  observados,  a  doenc¸a  progride  em
seu curso  natural  e  costuma  levar  a  óbito  pacientes  muito  jovens.  Dismorﬁsmo  facial,  retardo
de crescimento,  retardo  mental  e  displasia  esquelética  ou  articular  são  os  sinais  e  sintomas
mais frequentemente  observados  nesses  pacientes.
Objetivo:  A  ﬁnalidade  do  presente  estudo  foi  apresentar  os  tipos  de  perda  auditiva  e  os  achados
timpanométricos  de  pacientes  com  MPS  encaminhados  para  nossa  clínica  com  suspeita  de  perda
auditiva.
Método: Em  seguida  ao  exame  otorrinolaringológico,  nove  pacientes  com  diferentes  tipos  de
MPS, foram  submetidos  a  avaliac¸ões  imitanciométricas  e  testes  audiométricos  de  acordo  com
sua faixa  etária  eﬁciência  física  e  mental,  no  intuito  de  identiﬁcar  seus  limiares  auditivos.
Resultados:  Os  achados  audiométricos  dos  nove  pacientes  acompanhados  por  MPS  foram
descritos separadamente  para  cada  caso.
Conclusão:  Baseado  na  alta  frequência  de  perda  auditiva  em  pacientes  com  MPS,  avaliac¸ão
audiológica  precoce  e  detalhada  é  altamente  desejável.  Para  tanto,  é  importante  que  sejam
realizados  avaliac¸ões  multidisciplinares  periódicas  e  sistemáticas.
© 2015  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Publicado  por
Elsevier Editora  Ltda.  Todos  os  direitos  reservados.
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antroduction
ucopolysaccharidosis  (MPS)  is  a  hereditary  lysosomal  stor-
ge  disease,  which  develops  due  to  the  deﬁciency  in
he  enzymes  that  play  a  role  in  the  metabolism  of
lycosaminoglycans  (GAG).  Progressive  GAG  accumulation
auses  advanced  growth  retardation,  skeletal  deformities,
earing  loss,  weak  joint  movement,  and  facial  dysmorphism.
n  accordance  with  the  deﬁciency  of  the  known  11  enzymes,
PS  has  seven  sub-types  (MPS  I,  MPS  II,  MPS  III,  MPS  IV,
PS  VI,  MPS  VII,  MPS  IX).  Although  the  incidence  of  MPS  in
ccordance  with  its  sub-types  varies,  a  general  incidence  of
/25,000  has  been  reported.1--3
In  patients  with  MPS,  hearing  loss  is  observed  due  to  var-
ous  reasons.  Conductive  hearing  loss  (CHL)  may  develop
ue  to  recurrent  upper  respiratory  tract  infections  and
erous  otitis  media  or  bone  chain  deformities.  Sensorineural
earing  loss  (SHL)  is  thought  to  be  caused  due  to  the  accu-
ulation  of  GAG  in  the  cochlea,  auditory  nerve,  and  braintem.  In  many  patients,  mixed-type  hearing  loss,  along  with
he  symptoms  of  conductive  and  sensorineural  hearing  loss,
an  also  be  seen.  In  CHL  related  to  middle  ear  effusion,  while
he  ventilation  tube  implementation  is  frequently  used  as
e
n
w
treatment,  hearing  aids  are  advised  in  SHL.4--7 Early  diag-
osis  of  hearing  losses  carries  great  importance  in  terms  of
arly  intervention  in  MPS  patients,  as  well  as  in  all  other
atients.8,9
The  purpose  of  the  present  study  was  to  present  the
earing  loss  type,  degree,  and  tympanometric  ﬁndings  of
atients  with  MPS,  who  are  directed  to  this  clinic  with  the
uspicion  of  hearing  loss.
ethods
he  nine  patients  who  had  been  directed  to  this  department
ith  the  suspicion  of  hearing  loss,  whose  follow-up  had  been
onducted  after  they  have  been  diagnosed  with  MPS,  were
ncluded  in  this  study  (Ethical  Committee  approval  number:
ÜKAEK-461).  The  otological  examinations  of  the  patients
ere  performed  by  the  otorhinolaryngologist.  Information
elated  to  each  patient’s  otorhinolaryngological  complaints
nd  treatments  were  compiled  and  middle  ear  infection,
ar  discharge,  tinnitus,  dizziness,  tympanum  problems,  ade-
oidectomy,  ear  tube  placement,  and  hearing  aid  usage
ere  determined.  After  the  otorhinolaryngological  examina-
ion,  the  immitancemetric  evaluations  were  conducted  and
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Table  1  Degree  of  hearing  loss  (dB  HL).
Degree  of  hearing  loss  Hearing  loss  range  (dB  HL)
Normal  −10  to  15
Slight 16--25
Mild  26--40
Moderate  41--55
Moderately  severe 56--70
Severe  71--90
Profound 90+
Table  2  Tympanogram  types  (daPa).
Tympanogram  type  Pressure  intervals  (daPa)
Type  A  +50  to  (−150)
Type  B  −400
Type  C  −150  to  (−399)
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atests  which  are  appropriate  for  the  patients’  ages,  physical
and  mental  efﬁciencies,  and  both  air  and  bone  conduction
thresholds  were  determined  at  250,  500,  1000,  2000,  4000,
6000,  and  8000  Hz.
The  hearing  loss  levels  were  determined  by  taking  the
average  of  pure  tone  air  conduction  thresholds,  determined
at  0.5,  1,  2,  and  4  kHz,  in  accordance  with  the  intervals  given
in  Table  1.
Hear  loss  was  classiﬁed  under  three  groups  as  conductive,
mixed,  and  sensorineural.  For  CHL,  while  the  bone  hearing
thresholds  were  present  audiometrically  (less  than  20  dB),  it
has  been  accepted  that;  the  average  air-bone  gap  in  0.5,  1,
2  kHz  to  be  more  than  15  dB;  in  mixed  type  hearing  losses,
bone  hearing  thresholds  to  be  20  dB  and  over  audiometrically
and  the  average  air-bone  gap  to  be  more  than  15  dB  in  0.5,
1,  2  kHz;  in  sensorineural  hearing  loss  (SHL),  the  difference
between  the  air  and  bone  conduction  thresholds  to  be  less
than  15  dB  in  average  in  0.5,  1,  2  kHz.
In  the  tympanometrical  evaluation,  225  Hz  probe  tone
signals  were  used.  The  tympanogram  types  were  evaluated
in  accordance  with  the  values  given  in  Table  2.
3
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Table  3  Audiometrical  ﬁndings  of  patients  with  MPS.
Patient  Agea Diagnosis  Tympanometrical  ﬁndings  Ty
Right  Left  Rig
MÖ  9  MPS  VI  Type  C  Type  A  Co
EÖ 4  MPS  VI  Type  C  Type  C  Mi
I˙K 3  MPS  I  Type  B  Type  B  Mi
I˙K2 3  MPS  I  Type  B  Type  B  Mi
EC¸ 9  MPS  VI  Type  B  Type  B  Co
SD 8  MPS  IV  Type  B  Type  B  Mi
BEB 6  MPS  I  Type  B  Type  B  Co
MSE 7  MPS  IV  Type  B  Type  B  Mi
YCE 2  MPS  III  Type  B  Type  B  Mi
a In years.283
tatistical  analysis
or  the  statistical  analysis,  SPSS  version  16.0  (SPSS  Inc.,
hicago,  IL,  United  States)  was  used.  For  the  age  aver-
ge  and  standard  deviation  (SD),  descriptive  statistics  were
eveloped.
esults
he  age  average  of  the  total  of  nine  patients  with  MPS,  four
emale  (44.44%)  and  ﬁve  male  (55.55%),  was  determined
s  5.66  ±  2.73.  There  were  three  cases  of  MPS  VI  (33.33%),
hree  cases  of  MPS  I (33.33%),  one  case  of  MPS  III  (11.11%),
nd  two  cases  of  MPS  IV  (22.22%)  that  were  diagnosed.  Cases
Ö  and  EÖ  are  siblings; I˙K  and I˙K  2  are  twins.  The  other
ve  patients  are  not  related.  The  degree  of  hearing  loss,  its
ype,  and  tympanometrical  ﬁndings  are  shown  in  Table  3.
here  were  six  ears  with  conductive  hearing  loss  (33.33%)
HL  one  ear:  slight;  HL  one  ear:  mild;  HL  two  ears:  moderate,
nd  HL  two  ears:  moderately  severe);  12  ears  with  mixed
earing  loss  (66.66%)  (HL  two  ears:  mild;  HL  four  ears:  mod-
rate,  HL  ﬁve  ears:  severe,  and  HL  one  ear:  profound)  were
etermined.  There  were  14  ears  with  Type  B  tympanogram
77.77%),  three  ears  with  Type  C  tympanogram  (16.66%),  and
ne  ear  with  Type  A  tympanogram  (5.55%).  E.C¸.,  B.E.B.,  and
SE  had  a  bilateral  ventilation  tube  (VT)  inserted.  Although
he  other  patients  were  advised  regarding  the  VT  applica-
ion  as  well,  it  has  not  been  carried  out  upon  the  wish  of
heir  families.  With  the  exception  of  MÖ  and  BEB,  although
ll  patients  were  advised  to  use  hearing  aids,  the  families
id  not  adopt  the  use  of  these  devices  and  did  not  come
egularly  for  follow-ups.
iscussion
n  cases  with  MPS  (Table  4),  the  initiation  of  treatment
n  early  stages  carries  great  importance  in  terms  of  the
rognosis  of  the  disease.  However,  due  to  the  late  appear-
nce  of  the  symptoms,  the  deﬁnite  diagnosis  range  is
--4  years  of  age.  In  the  follow-up  of  the  stages  of  the
reatments  of  patients  with  MPS,  the  otolaryngologist  and
udiologists  have  a  signiﬁcant  role  in  multidisciplinary
eamwork.  Recurrent  serous  otitis  media  and  hearing  loss
pe  of  hearing  loss  Degree  of  hearing  loss
ht  Left  Right  Left
nductive  Conductive  Slight  Mild
xed  Mixed  Moderate  Moderate
xed  Mixed  Severe  Severe
xed  Mixed  Severe  Severe
nductive  Conductive  Moderate  Moderately  severe
xed  Mixed  Moderate  Mild
nductive  Conductive  Moderate  Moderately  severe
xed  Mixed  Moderate  Moderate
xed  Mixed  Severe  Profound
284  
Table  4  Air  and  bone  conduction  thresholds  of  patients
with MPS  (dB  HL).
Patient  Average  air
conduction
thresholds
(500--4000  Hz)
Average  bone
conduction
thresholds
(500--4000  Hz)
Right  Left  Right  Left
MÖ  22.5  26.25  6.25  6.25
EÖ 65  57.5  30  30
I˙K 70a 35b
I˙K2  70a 45b
EC¸ 46.25  60  12.5  12.5
SD 47.5  38.75  18.75  22.5
BEB 51.25  56.25  15  15
MSE 43.75 45  18.75 18.75
YCE  81.25 90  22.5 22.5
a The air conduction thresholds have been determined in free
ﬁeld.
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1b The bone conduction thresholds have been determined in
accordance with the speech recognition thresholds.
hat  develops  in  individuals  within  this  disease  group  are
he  reasons  why  better,  long-term  follow-ups  should  be
one.  Hearing  loss  can  be  seen  in  various  types  and  degrees
n  MPS  in  general.10--13 Overall,  conductive  hearing  losses
ue  to  chronic  effusion  and  eustachian  tube  dysfunction
re  seen  more  in  patients  with  MPS;  the  incidence  of  SHL
as  not  been  determined  very  clearly.10
Although  conductive  and  mixed-type  hearing  loss  were
bserved  in  the  cases  of  the  present  study,  SHL  compatible
ith  literature  has  not  been  determined.  In  the  studies  con-
ucted,  it  was  stated  that  the  incidence  of  mixed  hearing
oss  is  more,  and  that  this  fact  is  related  with  age.  While
onductive  hearing  loss  is  determined  in  early  ages  and  in
atients  who  are  diagnosed  earlier,  it  has  been  stated  that
ixed  hearing  loss  can  be  observed,  and  that  this  rate  is
etween  33%  and  71%  as  age  increases.  In  the  present  cases,
egree  of  hearing  loss  was  determined  from  slight  to  severe.
his  difference  is  considered  to  be  due  to  GAG’s  exces-
ive  accumulation  in  the  cochlear  ducts,  stria  vascularis,
nd  cochlear  nerve,  which  prevents  them  from  functioning
fﬁciently.14 In  the  present  cases,  the  incidence  of  Type  B
nd  C  tympanogram  was  determined  to  be  high,  in  accor-
ance  with  the  literature.  According  to  Yu  Lin  et  al.,  while
his  rate  is  stated  to  reach  70%,  the  incidence  of  Type  B
ympanogram  was  determined  as  77.77%  and  the  incidence
f  Type  C  tympanogram  was  determined  as  16.66%  in  the
resent  study,  similarly.  VT  application  is  advised  to  cases
ith  similar  clinical  ﬁndings  in  different  clinics  as  well,  just
s  in  the  present  study.  However,  a  majority  of  the  cases
n  this  study  have  hindered  their  treatments,  due  to  their
amilies’  rejection  of  the  VT  application.  In  cases  for  which
earing  aids  are  advised,  while  socio-economical  inadequacy
reates  hardships  in  coming  to  follow-ups  and  obtaining
hese  aids,  the  fact  that  many  live  in  different  cities  pre-
ents  continuity  in  follow-ups.
1Gökdog˘an  C¸ et  al.
onclusion
n  cases  with  MPS,  since  the  incidence  of  hearing  loss  is  high,
he  hearing  loss  should  be  determined  in  early  stages.  After
he  diagnosis,  the  required  treatments  should  be  started
romptly  and  thus  quality  of  life  should  be  increased.  How-
ver,  it  is  considered  that  this  is  only  possible  as  a  result  of
egular  and  systematic  follow-ups  and  with  multidisciplinary
tudies.
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